Scott M. Giacobello
CIK 1754154 · CHIEF FINANCIAL OFFICER · last filed 2026-05-18
Scott M. Giacobello is a CHIEF FINANCIAL OFFICER who has filed 23 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider was granted $150.0K of WHWK on May 18, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.39M
3
23
-$1.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | CHIEF FINANCIAL OFFICER | 333,489 | $4.16 | $1.39M | -$890.6K | 5 | 2026-05-18 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | CHIEF FINANCIAL OFFICER | 26,750 | $2.05 | $54.8K | -$6.6K | 6 | 2025-03-03 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Financial Officer | 161,120 | $218.96 | $35.28M | -$131.3K | 11 | 2021-03-04 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | WHWK | Grant (A) | +38,265 | $150.0K | EDGAR |
| 2026-04-17 | WHWK | Sell (S) | −218,600 | -$882.0K | EDGAR |
| 2026-04-03 | WHWK | Mixed | +473,902 | $0 | EDGAR |
| 2026-03-10 | WHWK | Mixed | +4,156 | -$8.6K | EDGAR |
| 2025-04-03 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-03-03 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Mixed | +3,944 | -$6.6K | EDGAR |
| 2024-03-04 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-27 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | +20,000 | $250.0K | EDGAR |